Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
5.56
+0.72 (14.88%)
At close: Dec 5, 2025, 4:00 PM EST
5.67
+0.11 (1.97%)
After-hours: Dec 5, 2025, 7:56 PM EST
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $186.69 million as of December 5, 2025. Its market cap has increased by 299.23% in one year.
Market Cap
186.69M
Enterprise Value
171.85M
1-Year Change
299.23%
Ranking
Category
Stock Price
$5.56
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $186.69M, an increase of 183.97%. That is a compound annual growth rate of 30.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 186.69M | 208.50% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.57B |
| Johnson & Johnson | 489.57B |
| AbbVie | 403.97B |
| UnitedHealth Group | 299.55B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 252.20B |
| Abbott Laboratories | 218.00B |